Inventor · disambiguated record
Yasutomo Nasu
Also filed as: NASU YASUTOMO
7 granted patents·3 pending applications·30 citations·filing 2006–2015
82Inventor score
Top patents by PatentIndex Score
10 records- 0192US10071126B2Conditionally replicating adenovirus to express REIC geneNAT UNIV CORPORATION OKAYAMA UNIV·Filed 2015·Granted Sep 11, 2018·9 cites·6 claims
- 0288US8658611B2Apoptosis-inducing agent for prostate cancer cellsKUMON HIROMI·Filed 2011·Granted Feb 25, 2014·7 cites·6 claims
- 0377US8618273B2Partial fragment of REIC/Dkk-3 gene and cancer therapeutic agent comprising the sameKUMON HIROMI·Filed 2007·Granted Dec 31, 2013·4 cites·7 claims
- 0476US8658612B2Therapeutic agent for malignant mesothelioma and immunostimulantKUMON HIROMI·Filed 2009·Granted Feb 25, 2014·3 cites·3 claims
- 0575US9475865B2Direct administration of REIC/Dkk-3 to mesotheliomaKUMON HIROMI·Filed 2013·Granted Oct 25, 2016·2 cites·2 claims
- 0674US8614093B2Pharmaceutical composition for treating or preventing cancer by inducing dendritic cell-like differentiation from monocytes to improve anticancer immune activityKUMON HIROMI·Filed 2009·Granted Dec 24, 2013·2 cites·4 claims
- 0773US8946173B2Cancer cell death inducing agent having effects of potentiating anticancer drug against anticancer-drug-resistant cancerKUMON HIROMI·Filed 2008·Granted Feb 3, 2015·3 cites·3 claims
- 0849US2009005538A1Apoptosis-Inducing Agent for Prostate Cancer CellsKUMON HIROMI·Filed 2006·Application pending·0 cites
- 0948US2015284444A1Pharmaceutical composition for cancer treatment including fusion proteinWATANABE MASAMI·Filed 2013·Application pending·0 cites
- 1045US2014056945A1Pharmaceutical composition for treating or preventing cancer by inducing dendritic cell-like differentiation from monocytes to improve anticancer immune activityMOMOTARO GENE INC·Filed 2013·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Yasutomo Nasu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →